Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether HMG-CoA reductase inhibitor, atorvastatin
attenuates inflammation in atherosclerotic plaques detected by 18F-fluorodeoxyglucose(FDG)
PET.